Results 41 to 50 of about 1,142,872 (298)

Acute Myeloid Leukemia (AML): The Role of Intensive Induction Chemotherapy [PDF]

open access: yesInternational Journal of Hematology-Oncology and Stem Cell Research, 2004
Intensive induction therapy-in acute myeloid leukemia (AML), as in some other systemic malignancies- is a strategy fundamentally different from post-remission strategies.
Thomas Büchner   +27 more
doaj   +2 more sources

Cyclosporine for induction of remission in Crohn's disease

open access: yesCochrane Database of Systematic Reviews, 2005
Cyclosporine was first found to be an effective and well-tolerated immunosuppressive agent in organ transplant recipients, and subsequently in several autoimmune diseases. It was reported in open studies that cyclosporine is effective for induction of remission in Crohn's disease.
McDonald, John WD   +5 more
openaire   +2 more sources

Induction and maintenance of remission with mycophenolate mofetil in ANCA-associated vasculitis: a systematic review and meta-analysis

open access: yes, 2021
Background: Uncertainties exist about the use of mycophenolate mofetil (MMF) in anti-neutrophil cytoplasmatic antibody (ANCA)-associated vasculitis (AAV), particularly for remission maintenance.
신재일   +13 more
core   +1 more source

Post-Induction Remission Status in B-Acute Lymphoblastic Leukemia Patients (B-ALL),  Experience at Tertiary Care Hospital

open access: yesPakistan Armed Forces Medical Journal
Objectives: To determine the frequency of post-induction remission status and its association with cytogenetic and molecular abnormalities in patients with B-ALL. Study Design: Cross-sectional Analytical study.
Sumaira Ilyas   +5 more
doaj   +1 more source

Prediction of response to remission induction therapy by gene expression profiling of peripheral blood in Japanese patients with microscopic polyangiitis

open access: yesArthritis Research & Therapy, 2017
Background Microscopic polyangiitis (MPA), which is classified as an anti-neutrophil cytoplasmic antibody (ANCA)-associated small vessel vasculitis, is one of the most frequent primary vasculitides in Japan.
Akihiro Ishizu   +18 more
doaj   +1 more source

Vedolizumab for induction and maintenance of remission in Crohn's disease [PDF]

open access: yes, 2023
Vedolizumab blocks inflammatory activity within the gastrointestinal tract. Systematic reviews have demonstrated the efficacy of vedolizumab in ulcerative colitis and inflammatory bowel disease in general.
Vassiliki Sinopoulou   +13 more
core   +1 more source

Venetoclax‐Based Therapy as a Bridge to Hematopoietic Stem Cell Transplantation in Relapsed or Refractory Pediatric Acute Leukemia

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Relapsed and/or refractory (R/R) pediatric acute leukemia carries a dismal prognosis, largely driven by chemoresistance to conventional salvage therapy. The BH3‐mimetic venetoclax, combined with chemotherapy or hypomethylating agents, has demonstrated efficacy in small clinical trials.
Katherine S. Colman   +9 more
wiley   +1 more source

Biphasic Clinical Course of Pediatric Cytomegalovirus‐Associated Immune Thrombocytopenia: Early Poor Treatment Response but Favorable Long‐Term Outcomes

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background Cytomegalovirus (CMV) is a recognized trigger of immune thrombocytopenia (ITP); however, its incidence and impact on disease course in children remain controversial. Therefore, we aimed to characterize the clinical course of pediatric patients with CMV‐associated ITP.
Oded Gilad   +9 more
wiley   +1 more source

Aminosalicylates for induction of remission or response in Crohn's disease [PDF]

open access: yesCochrane Database of Systematic Reviews, 2016
Randomized trials investigating the efficacy of aminosalicylates for the treatment of mildly to moderately active Crohn's disease have yielded conflicting results. A systematic review was conducted to critically examine current available data on the efficacy of sulfasalazine and mesalamine for inducing remission or clinical response in these patients ...
Wee-Chian, Lim   +3 more
openaire   +2 more sources

Influence of Cytokines and Autologous Lymphokine-Activated Killer Cells on Leukemic Bone Marrow Cells and Colonies in AML [PDF]

open access: yes, 2001
We have already shown that cytokine cocktails (IL-1 beta, IL-3, IL-6, SCF, GM-CSF) and/or lymphokine-activated killer (LAK) cells can reduce the amounts of clonal, CD34-positive mononuclear bone marrow cells (BM-MNC) in acute myeloid leukemia (AML).
Gerhartz, Helmut Heinrich   +2 more
core   +1 more source

Home - About - Disclaimer - Privacy